Overview of IBC

The US National Institutes of Health (NIH) Guidelines require that an Institutional Biosafety Committee (IBC) be established to screen research proposals involving recombinant DNA molecules. This is not only mandatory for institutions seeking NIH funding but it is also critical to the safe conduct of research of this nature and to the fulfillment of an institutional commitment to the protection of staff, the environment, and public health.